Vintafolide

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Key facts

Vintafolide is a drug catalogued in DrugCentral. Recorded indications include Malignant epithelial tumor of ovary.

• Indications: Malignant epithelial tumor of ovary.
• ATC code: L01CA06 (Vinca alkaloids and analogues).
• Molecular formula: C86H109N21O26S2; molecular weight 1917.06 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Malignant epithelial tumor of ovary

ATC classification

ATC code	Therapeutic hierarchy
L01CA06	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS › Vinca alkaloids and analogues

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Vintafolide is on its molecule page.

• Molecular formula: C₈₆H₁₀₉N₂₁O₂₆S₂
• Molecular weight: 1917.06 g/mol
• CAS number: 742092-03-1
• InChIKey: KUZYSQSABONDME-QRLOMCMNSA-N
• PubChem CID: 25014653

CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1=C(NC3=CC=CC=C13)[C@@](C2)(C(=O)OC)C1=C(OC)C=C2N(C)[C@@H]3[C@]4(CCN5CC=C[C@](CC)([C@@H]45)[C@@H](O)[C@]3(O)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)CC[C@H](NC(=O)C3=CC=C(NCC4=CNC5=NC(N)=NC(=O)C5=N4)C=C3)C(O)=O)C(O)=O)C2=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Vintafolide used for?

DrugCentral lists the following indications for Vintafolide: Malignant epithelial tumor of ovary.

What is the chemical formula of Vintafolide?

Vintafolide has the molecular formula C86H109N21O26S2 and a molecular weight of 1917.06 g/mol.

Sources

• DrugCentral drug card 4831 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL3039521 — compound record and bioactivity
• PubChem CID 25014653 — chemical identifiers
• DrugBank DB05168 — drug record
• FDA UNII 36O410ZD4I — substance identity

How this page is built: methodology · editorial policy & corrections.